Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Actavis Plc (NY: )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Actavis Plc

< Previous 1 2 3 4 5 6 7 8 9
...
38 39 Next >
Emergency Medicine of the Future Demonstrated at ACEP15
"InnovatED" to Feature Emergency Simulations and Next Generation Technology 
From PR Newswire
Allergan Anti-Infective Portfolio Highlighted in 13 Abstracts at IDWeek 2015
Allergan plc (NYSE: ACT) today announced that its infectious disease portfolio will be featured in 13 abstracts highlighting data at IDWeek 2015, which takes place from October 7-11, 2015, in San... 
From PR Newswire
3 Underappreciated Israeli Stocks to Buy
 
Tags Stocks to Buy NYSEARCA:EIS NYSE:ACT
From InvestorPlace
Allergan PLC Edges Out Earnings Estimates
Allergan released its latest earnings report before opening bell this morning, posting non-GAAP earnings of $4.41 per share, a 29% increase year over year, on $5.76 billion in revenue, a 116%. 
Tags Stocks / Equities Healthcare
From Blogs - TalkMarkets
Allergan Reports Exceptional Second Quarter 2015 Performance with 116% Increase in Net Revenue to $5.76 Billion and 29% Growth in Non-GAAP EPS to $4.41
-- Adjusted EBITDA Increases 203% to $2.6 Billion in Second Quarter 2015 -- 
From PR Newswire
5 Biotechs With Catalysts Coming This Week
In a report issued Monday, Chardan Capital Markets’ Managing Director and Head of Healthcare Research Gbola Amusa looked into ... 
Tags Gbola Amusa Trading Ideas Price Target
From Benzinga
Delivering Alpha: What's Coming?
CNBC/Institutional Investor's Fifth Annual "Delivering Alpha" conference is set to kick off on Wednesday at the iconic Pierre hotel in ... 
Tags MWV OAS ACT
From Benzinga
Valeant – Zoetis Chatter Dominates Wall Street
Valeant Pharmaceuticals may or may not be interested in buying Zoetis, but is Zoetis even interested in being acquired by Valeant? That is the key question as rumors about a Valeant/Zoetis potential... 
Tags Pharma/Biotech Stocks / Equities Healthcare
From Blogs - TalkMarkets
Company Update (NYSE:ACT): Eli Lilly wins UK Alimta drug patent case on appeal, shares jump
[Reuters – UK Focus] – Eli Lilly has won a patent case in the Court of Appeal in London over its blockbuster Alimta lung cancer drug, boosting prospects for future sales and dealing . . . → Read More:... 
Tags News NYSE:ACT Finance
From Jutia Group
3 Best Vanguard Funds for a Defensive Portfolio
 
Tags NYSEARCA:VDC MUTF:VGHCX NYSE:D
From InvestorPlace
Best Mutual Funds for Investing in Healthcare Stocks
 
Tags MUTF:JAGLX NYSE:ACT NYSE:BMY
From InvestorPlace
The Best Mutual Funds to Buy for the Rest of 2015
 
Tags MUTF:PRISX Mutual Funds NYSE:C
From InvestorPlace
PJP, ACT, LGND, DEPO: Large Outflows Detected at ETF
Symbols mentioned in this story: PJP, ACT, LGND, DEPO Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
Doctor on Demand: Changing the face of medical care
Jim Cramer goes off the tape to speak to the CEO of Doctor on Demand, and how it is changing the way doctors treat & diagnose patients. 
Tags Investing/Indexes/S&P 500 Investing/Stock Market/Stock Picks Actavis PLC
From CNBC.com News
Eastman Receives Top Honor for College and Career Readiness
Tags Eastman Volunteerism & Community Engagement National College and Career Readiness Program
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Which 12 Gurus All Hold Actavis?
When hedge fund manager "titans" think alike, investors are wise to pay attention. At Holdings Channel, we have reviewed 4,024 13F filings for the 03/31/2015 reporting period, and noticed that Actavis... 
Tags Stocks
From Market News Video
My Top 3 Fabulous Pharma Stocks
These three Pharma companies offer intriguing potential for above-average future long-term earnings growth. Importantly, based on that earnings growth potential, each of them appear soundly valued at... 
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Microsoft, Apple & Actavis Among Hedgies', Mutual Fund's Favorite Stocks
In a report published Friday, Citigroup analyst Tobias Levkovich offered a glimpse in to what hedge funds and mutual funds are buying ... 
Tags TWC Benzinga VRX
From Benzinga
10 Reasons Why Growth Stocks Can Be Appropriate For Retired Investors
I believe that adding growth stocks to retirement portfolios can be appropriate under certain circumstances. With this article I offered a few reasons and situations where that might be the case. 
Tags Pharma/Biotech Healthcare Technology
From Blogs - TalkMarkets
Cramer Remix: When to buy Rite Aid's stock
"Mad Money" host Jim Cramer calls out his price to buy a hot stock in the healthcare business. 
Tags Investing/Stock Market Investing Mad Money
From CNBC.com News
Cramer: Serial acquirers raking in major dough
As Jim Cramer worries about the economy slowing, he found four companies that are in the sweet spot to generate major cash for your portfolio. 
Tags Valeant Pharmaceuticals International Inc Investing/Indexes/S&P 500 Investing/Stock Market/Stock Picks
From CNBC.com News
Orexigen, Takeda file suit against Actavis to stop generic diet pill
June 5 (Reuters) - Orexigen Therapeutics Inc and partner Takeda Pharmaceutical Co Ltd said they had filed a lawsuit against Actavis Plc to block a generic version of diet-pill Contrave. 
Tags companyNews
From Reuters: Company News
M&A boom: It's different this time
NEW YORK, June 5 (IFR) - An M&A boom usually spells trouble for bondholders, as it typically means soaring debt to finance the acquisitions, but analysts say the current takeover frenzy is no cause for... 
Tags companyNews
From Reuters: Company News
Actavis Announces FDA Approval of NATRELLE INSPIRA™ Round Gel-Filled Textured Breast Implants
- Company now offers the industry's widest range of breast implant options - 
From PR Newswire
Company Update: Actavis plc (NYSE:ACT) – Actavis Announces FDA Approval of NATRELLE INSPIRA™ Round Gel-Filled Textured Breast Implants
[PR Newswire] – DUBLIN, June 4, 2015 /PRNewswire/ — Actavis plc (ACT), which recently completed the acquisition of Allergan, Inc., today announced that the company has received approval from the U.S.... 
Tags Health Markets Stock
From Jutia Group
BofA On Actavis: 'ACT Now And Don't Wait Much Longer'
In a report published on Thursday, Bank of America Merrill Lynch analyst Sumant S. Kulkarni maintained a Buy rating on Actavis plc ... 
Tags ACT Analyst Color Price Target
From Benzinga
Analyst Knocks High-Profile Biotech Merger Battle; Opportunities Elsewhere
Three companies locked in a high-profile bidding battle each got merely average marks from an analyst Wednesday, who launched ... 
Tags ACT TEVA LCI
From Benzinga
Company Update: Actavis plc (NYSE:ACT) – Actavis to Present at the Goldman Sachs 36th Annual Global Healthcare Conference
[PR Newswire] – DUBLIN, June 3, 2015 /PRNewswire/ — Actavis plc (NYSE: ACT), a leading global pharmaceutical company, today announced that Brent Saunders, CEO and President of Actavis, will provide an... 
Tags Health Markets Healthcare
From Jutia Group
Actavis to Present at the Goldman Sachs 36th Annual Global Healthcare Conference
From PR Newswire
VUG, ORCL, AMGN, ACT: ETF Outflow Alert
Symbols mentioned in this story: VUG, ORCL, AMGN, ACT Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
< Previous 1 2 3 4 5 6 7 8 9
...
38 39 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.